Cargando…
Molecular basis for inhibiting human glucose transporters by exofacial inhibitors
Human glucose transporters (GLUTs) are responsible for cellular uptake of hexoses. Elevated expression of GLUTs, particularly GLUT1 and GLUT3, is required to fuel the hyperproliferation of cancer cells, making GLUT inhibitors potential anticancer therapeutics. Meanwhile, GLUT inhibitor-conjugated in...
Autores principales: | Wang, Nan, Zhang, Shuo, Yuan, Yafei, Xu, Hanwen, Defossa, Elisabeth, Matter, Hans, Besenius, Melissa, Derdau, Volker, Dreyer, Matthias, Halland, Nis, He, Kaihui Hu, Petry, Stefan, Podeschwa, Michael, Tennagels, Norbert, Jiang, Xin, Yan, Nieng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098912/ https://www.ncbi.nlm.nih.gov/pubmed/35552392 http://dx.doi.org/10.1038/s41467-022-30326-3 |
Ejemplares similares
-
Exofacial epitope-tagged glucose transporter chimeras reveal COOH- terminal sequences governing cellular localization
Publicado: (1993) -
Cryo-EM structure of human glucose transporter GLUT4
por: Yuan, Yafei, et al.
Publicado: (2022) -
Facile folding of insulin variants bearing a prosthetic C-peptide prepared by α-ketoacid-hydroxylamine (KAHA) ligation
por: Boross, Gábor N., et al.
Publicado: (2018) -
Tyrosine Kinase Inhibitors Reduce Glucose Uptake by Binding to an Exofacial Site on hGLUT‐1: Influence on (18)F‐FDG PET Uptake
por: Damaraju, Vijaya L., et al.
Publicado: (2021) -
Exofacial membrane composition and lipid metabolism regulates plasma membrane P4-ATPase substrate specificity
por: Jain, Bhawik Kumar, et al.
Publicado: (2021)